INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
50 hedge funds and large institutions have $71.2M invested in Inozyme Pharma in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 9 closing their positions.
Holders
50
Holders Change
-1
Holders Change %
-1.96%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
13
Reduced
17
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | – | -88,921 | Closed |
|
52
Marshall Wace
London,
United Kingdom
| – | – | -36,033 | Closed |
|
53
Millennium Management
New York
| – | – | -19,952 | Closed |
|
54
Walleye Capital
New York
| – | – | -15,588 | Closed |
|
|
E
55
Ergoteles
New York
| – | – | -12,200 | Closed |
|
56
Acadian Asset Management
Boston,
Massachusetts
| – | – | -3,676 | Closed |
|
|
AWA
57
Amplius Wealth Advisors
Blue Bell,
Pennsylvania
| – | – | -1,000 | Closed |
|
58
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $0 | 2 | – | – |
|
|
CFGS
59
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
EI
60
Ellevest Inc
New York
| $0 | 38 | +38 | New |
|